Skip to main content

Search

10 result(s) for 'author#Michelino De Laurentiis' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. Metabolic syndrome (MS) has been shown to increase the risk of breast cancer. Existing data suggest that the strength of metabolic syndrome-breast cancer link varies by intrinsic molecular subtype, but results...

    Authors: Immacolata Capasso, Emanuela Esposito, Michelino de Laurentiis, Nicola Maurea, Ernesta Cavalcanti, Gerardo Botti, Antonella Petrillo, Maurizio Montella, Massimiliano D’Aiuto, Carmela Coppola, Anna Crispo, Maria Grimaldi, Giuseppe Frasci, Alfredo Fucito, Gennaro Ciliberto and Giuseppe D’Aiuto
    Citation: Diabetology & Metabolic Syndrome 2014 6:105
    Content type: Research Published on:

  2. Coronavirus disease 2019 (COVID-19) global pandemic has created unique challenges to healthcare systems throughout the world. Ensuring subjects’ safety is mandatory especially in oncology, in consideration of ...

    Authors: Maria Antonietta Isgrò, Maria Grazia Vitale, Egidio Celentano, Flavia Nocerino, Giuseppe Porciello, Marcello Curvietto, Domenico Mallardo, Concetta Montagnese, Luigi Russo, Nicoletta Zanaletti, Antonio Avallone, Matilde Pensabene, Michelino De Laurentiis, Sara Centonze, Sandro Pignata, Lucia Cannella…
    Citation: Journal of Translational Medicine 2021 19:132
    Content type: Research Published on:

  3. Inositol has been reported to improve insulin sensitivity since it works as a second messenger achieving insulin-like effects on metabolic enzymes. The aim of this study was to evaluate the inositol and alpha ...

    Authors: Immacolata Capasso, Emanuela Esposito, Nicola Maurea, Maurizio Montella, Anna Crispo, Michelino De Laurentiis, Massimiliano D’Aiuto, Giuseppe Frasci, Gerardo Botti, Maria Grimaldi, Ernesta Cavalcanti, Giuseppe Esposito, Alfredo Fucito, Giuseppe Brillante, Giuseppe D’Aiuto and Gennaro Ciliberto
    Citation: Trials 2013 14:273
    Content type: Research Published on:

  4. COVID-19 pandemic following the outbreak in China and Western Europe, where it finally lost the momentum, is now devastating North and South America. It has not been identified the reason and the molecular mec...

    Authors: Franco M. Buonaguro, Gerardo Botti, Paolo Antonio Ascierto, Sandro Pignata, Franco Ionna, Paolo Delrio, Antonella Petrillo, Ernesta Cavalcanti, Maurizio Di Bonito, Sisto Perdonà, Michelino De Laurentiis, Francesco Fiore, Raffaele Palaia, Francesco Izzo, Stefania D’Auria, Virginia Rossi…
    Citation: Infectious Agents and Cancer 2020 15:69
    Content type: Methodology Published on:

  5. Empagliflozin (EMPA), a selective inhibitor of the sodium glucose co-transporter 2, reduced the risk of hospitalization for heart failure and cardiovascular death in type 2 diabetic patients in the EMPA‐REG OU...

    Authors: Vincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea, Antonio Barbieri, Maria Gaia Monti, Andreina Carbone, Andrea Paccone, Lucia Altucci, Mariarosaria Conte, Maria Laura Canale, Gerardo Botti and Nicola Maurea
    Citation: Cardiovascular Diabetology 2021 20:150
    Content type: Original investigation Published on:

  6. Circulating tumor cells (CTCs) represent an independent predictor of outcome in patients with metastatic breast cancer (MBC). We assessed the prognostic impact of CTCs according to different first-line systemi...

    Authors: Mario Giuliano, Antonio Giordano, Summer Jackson, Kenneth R Hess, Ugo De Giorgi, Michal Mego, Beverly C Handy, Naoto T Ueno, Ricardo H Alvarez, Michelino De Laurentiis, Sabino De Placido, Vicente Valero, Gabriel N Hortobagyi, James M Reuben and Massimo Cristofanilli
    Citation: Breast Cancer Research 2011 13:R67
    Content type: Research article Published on:

  7. Triple negative breast cancer (TNBC) is an aggressive disease characterized by high risk of relapse and development of resistance to different chemotherapy agents. Several targeted therapies have been investig...

    Authors: Stefania Cocco, Alessandra Leone, Maria Serena Roca, Rita Lombardi, Michela Piezzo, Roberta Caputo, Chiara Ciardiello, Susan Costantini, Francesca Bruzzese, Maria José Sisalli, Alfredo Budillon and Michelino De Laurentiis
    Citation: Journal of Translational Medicine 2022 20:290
    Content type: Research Published on:

  8. NEPA is an oral fixed-dose combination of netupitant, a new highly selective neurokinin-1 receptor antagonist, and palonosetron. This study was conducted to evaluate whether the efficacy of NEPA against chemot...

    Authors: Roberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, Rosalba Torrisi, Ida Paris, Monica Giordano, Vincenzo Montesarchio, Valentina Guarneri, Laura Amaducci, Domenico Bilancia, Giuseppina Cilenti, Alessandra Fabi, Elena Collovà, Alessio Schirone, Erminio Bonizzoni, Luigi Celio…
    Citation: BMC Cancer 2020 20:232
    Content type: Research article Published on:

  9. Stage shift is widely considered a major determinant of the survival benefit conferred by breast cancer screening. However, factors and mechanisms underlying such a prognostic advantage need further clarificat...

    Authors: Anna Crispo, Maddalena Barba, Giuseppe D’Aiuto, Michelino De Laurentiis, Maria Grimaldi, Massimo Rinaldo, Giuseppina Caolo, Massimiliano D’Aiuto, Immacolata Capasso, Emanuela Esposito, Alfonso Amore, Maurizio Di Bonito, Gerardo Botti and Maurizio Montella
    Citation: BMC Cancer 2013 13:15
    Content type: Research article Published on:

  10. Several trials evaluated the role of ovarian function suppression for the adjuvant treatment of premenopausal patients with hormone receptor-positive early breast cancer. Based on the results of the SOFT and T...

    Authors: Giacomo Pelizzari, Grazia Arpino, Laura Biganzoli, Saverio Cinieri, Michelino De Laurentiis, Lucia Del Mastro, Angelo Di Leo, Stefania Gori, Valentina Guarneri, Paolo Marchetti and Fabio Puglisi
    Citation: BMC Cancer 2018 18:932
    Content type: Research article Published on: